JANONE

janone-logo

JanOne is focused on developing treatments for diseases that cause severe pain. By alleviating pain at the source, JanOne aims to reduce the need for opioid prescriptions to treat disease associated pain that can lead to opioid abuse. The company is also exploring solutions for non-addictive pain medications. Its lead candidate JAN101 is for treating peripheral artery disease (PAD), a condition that affects over 8.5 million Americans. JAN101 demonstrated positive results in a Phase 2a clinical trial, and Phase 2b trials are expected to begin in early 2021.

#SimilarOrganizations #People #Financial #Website #More

JANONE

Industry:
Biotechnology Recycling

Founded:
1983-01-01

Address:
Minneapolis, Minnesota, United States

Country:
United States

Website Url:
http://www.janone.com

Total Employee:
51+

Status:
Active

Contact:
952-930-9000

Total Funding:
6 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Apache Wordpress Plugins


Similar Organizations

agriprotein-logo

Agriprotein

Agriprotein specializes in nutrient recycling to create sustainable sources of protein for the mono-gastric animal feed industry.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

forma-therapeutics-logo

FORMA Therapeutics

FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.

metis-therapeutics-logo

METiS Therapeutics

METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.

navrogen-logo

Navrogen

Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.


Current Advisors List

randy-pearce_image

Randy Pearce Member of the Board of Directors & Chair of the Audit Committee @ JanOne
Board_member

Current Employees Featured

armando-soto_image

Armando Soto
Armando Soto Founder @ JanOne
Founder

tony-giordano_image

Tony Giordano
Tony Giordano Chief Scientific Officer @ JanOne
Chief Scientific Officer

not_available_image

Jack Cameron
Jack Cameron Founder @ JanOne
Founder
1976-01-01

not_available_image

Tony Isaac
Tony Isaac CEO @ JanOne
CEO
2016-05-01

Founder


not_available_image

Jack Cameron

Stock Details


Company's stock symbol is NASDAQ:JAN

Acquisitions List

Date Company Article Price
2017-09-14 GeoTraq Inc. GeoTraq Inc. acquired by JanOne N/A

Official Site Inspections

http://www.janone.com Semrush global rank: 1.35 M Semrush visits lastest month: 21.4 K

  • Host name: 104.21.85.53
  • IP address: 104.21.85.53
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "JanOne"

Our Company - JanOne a biotech company to treat โ€ฆ

When we launched JanOne and entered into the world of pharmaceuticals, our aim was to ensure we remained true to maintaining businesses with social โ€ฆSee details»

JanOne - A Biotechnology Company

JanOne is a pharmaceutical company focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. As a result, we hope to reduce the need for โ€ฆSee details»

Company Information :: JanOne Inc. (ALTS)

JanOne is a pharmaceutical company focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. As a โ€ฆSee details»

JANONE CONFIRMS NAME CHANGE TO ALT5 SIGMA โ€ฆ

LAS VEGAS, July 12, 2024 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a multidisciplinary organization with a focus on fintech and healthcare, confirmed today that, as of market open on Monday, July 15, 2024, the Company's new โ€ฆSee details»

JanOne - Crunchbase Company Profile & Funding

JanOne is focused on developing treatments for diseases that cause severe pain. By alleviating pain at the source, JanOne aims to reduce the need for opioid prescriptions to treat disease โ€ฆSee details»

Corporate Governance :: JanOne Inc. (ALTS)

JanOne is a pharmaceutical company focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. As a โ€ฆSee details»

JanOne Inc. - AnnualReports.com

JanOne (NASDAQ: JAN) is focused on developing treatments for diseases that cause severe pain. By alleviating pain at the source, JanOne aims to reduce the need for opioid โ€ฆSee details»

JANONE CONFIRMS NAME CHANGE TO ALT5 SIGMA โ€ฆ

Jul 12, 2024 --JanOne Inc., a multidisciplinary organization with a focus on fintech and healthcare, confirmed today that, as of market open on Monday, July 15, 2024, the Company's โ€ฆSee details»

JanOne Company Profile - Office Locations, Competitors, Revenue โ€ฆ

Sep 12, 2024 JanOne has 5 employees at their 1 location and $39.61 m in annual revenue in FY 2022. See insights on JanOne including office locations, competitors, revenue, financials, โ€ฆSee details»

JanOne - Overview, News & Similar companies | ZoomInfo.com

View JanOne (www.janone.com) location in Nevada, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more. โ€ฆSee details»

Management Team :: JanOne Inc. (ALTS)

JanOne is a pharmaceutical company focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. As a result, we hope to reduce the need for โ€ฆSee details»

JanOne - Funding, Financials, Valuation & Investors - Crunchbase

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Aug 18, 2023: Post-IPO Equity โ€ฆSee details»

JanOne Announces Plan to Enhance Stockholder Value Through

Jul 10, 2024 JanOne is a unique Nasdaq-listed multidisciplinary organization with a focus on healthcare and fintech. JanOne is one of the constituents of the Russell Microcap Index, โ€ฆSee details»

JanOne's Subsidiary, Alt5, Reports 91% year over year increase in ...

Jun 13, 2024 About JanOne. JanOne is a unique Nasdaq-listed multidisciplinary organization with a focus on healthcare and fintech. JanOne is one of the constituents of the Russell โ€ฆSee details»

Frequently Asked Questions - JanOne - NASDAQ-Listed Company

The companyโ€™s name, JanOne, expresses the start of a new day and new beginnings. January One is the first day of a New Year โ€“ a day of optimism, resolution, and hope. JanOne affirms โ€ฆSee details»

JanOne Announces Plan to Enhance Stockholder Value Through

Jul 10, 2024 JanOne is a unique Nasdaq-listed multidisciplinary organization with a focus on healthcare and fintech. JanOne is one of the constituents of the Russell Microcap Index, โ€ฆSee details»

JanOne Announces Plan to Enhance Stockholder Value Through โ€ฆ

Jul 10, 2024 JanOne is a unique Nasdaq-listed multidisciplinary organization with a focus on healthcare and fintech. JanOne is one of the constituents of the Russell Microcap Index, โ€ฆSee details»

Board of Directors :: JanOne Inc. (ALTS)

Richard D. Butler, Jr. has been a director of the Company since May 2015. Mr. Butler is the owner of an advisory firm that provides real estate, corporate, and financial advisory services since โ€ฆSee details»

Tony Isaac โ€“ CEO - JanOne

Tony Isaac โ€“ CEO โ€“ Mr. Isaac has been a director of the Company since May 2015 and Chief Executive Officer of the Company since May 2016. Mr. Isaac has served as Financial Planning โ€ฆSee details»

Corporate Governance :: JanOne Inc. (JAN)

JanOne is a pharmaceutical company focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. As a โ€ฆSee details»

linkstock.net © 2022. All rights reserved